Wegovy Gets F.D.A. Approval for MASH

Wegovy has been approved for use among the growing number of Americans who have MASH.

News
How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

News
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

News
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

News
America’s Whey Protein Obsession Is Transforming the Dairy Industry

Whey, the liquid byproduct of cheese making, was once considered waste. Now it is a key ingredient in the protein powders that Ozempic users and weight lifters are downing in ever-greater amounts.

News
Study Suggests Weight-Loss Pill is as Effective as Ozempic

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.

News
In Some Ozempic Households, the Weight Loss is Contagious

Patients taking the drugs are finding their families are benefiting, too.

News
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

News
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

News
Wegovy Can Treat a Dangerous Liver Disease, Study Finds

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

News